77 related articles for article (PubMed ID: 4059214)
1. Taurine and failing heart: experimental and clinical aspects.
Azuma J; Takihara K; Awata N; Sawamura A; Ohta H; Hamaguchi T; Tanaka Y; Fukuda K; Kishimoto S
Prog Clin Biol Res; 1985; 179():195-213. PubMed ID: 4059214
[No Abstract] [Full Text] [Related]
2. Beneficial effect of taurine on congestive heart failure induced by chronic aortic regurgitation in rabbits.
Azuma J; Takihara K; Awata N; Ohta H; Sawamura A; Harada H; Kishimoto S
Res Commun Chem Pathol Pharmacol; 1984 Aug; 45(2):261-70. PubMed ID: 6484312
[TBL] [Abstract][Full Text] [Related]
3. [Pathomorphological and morphometric evaluation of a model of aortic insufficiency in rabbits treated with taurine].
Ryff IM; Elizarova EP; Orlova TsR; Faron RA; Puchkova VA; Petrusenko AN; Rudzhianskaĭte AF
Biull Eksp Biol Med; 1990 Jun; 109(6):600-3. PubMed ID: 2397307
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effect of taurine in rabbits with chronic congestive heart failure.
Takihara K; Azuma J; Awata N; Ohta H; Hamaguchi T; Sawamura A; Tanaka Y; Kishimoto S; Sperelakis N
Am Heart J; 1986 Dec; 112(6):1278-84. PubMed ID: 3788775
[TBL] [Abstract][Full Text] [Related]
5. Effects on heart membranes after taurine treatment in rabbits with congestive heart failure.
Elizarova EP; Orlova TR; Medvedeva NV
Arzneimittelforschung; 1993 Mar; 43(3):308-12. PubMed ID: 8387787
[TBL] [Abstract][Full Text] [Related]
6. Taurine for treatment of congestive heart failure in humans.
Azuma J; Hasegawa H; Awata N; Sawamura A; Harada H; Ogura K; Ohta H; Yamauchi K; Kishimoto S
Prog Clin Biol Res; 1983; 125():61-72. PubMed ID: 6348797
[No Abstract] [Full Text] [Related]
7. [The clinical efficacy of taufon in the combined treatment of patients with chronic circulatory failure].
Zavolovskaia LI; Elizarova EP; Orlov VA
Eksp Klin Farmakol; 1995; 58(6):29-32. PubMed ID: 8704607
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial.
Azuma J; Sawamura A; Awata N; Ohta H; Hamaguchi T; Harada H; Takihara K; Hasegawa H; Yamagami T; Ishiyama T
Clin Cardiol; 1985 May; 8(5):276-82. PubMed ID: 3888464
[TBL] [Abstract][Full Text] [Related]
9. [Taurine level in the blood and myocardium of rabbits with experimental heart failure].
Orlova TsR; Iakushkin VV; Elizarova EP
Fiziol Zh (1978); 1990; 36(6):3-7. PubMed ID: 2083583
[TBL] [Abstract][Full Text] [Related]
10. [Use of taurine in the treatment of experimental congestive heart failure].
Orlova TsR; Elizarova EP; Ryff IM; Fetisova NI; Mit'kina LI
Kardiologiia; 1991 Jun; 31(6):77-80. PubMed ID: 1921137
[TBL] [Abstract][Full Text] [Related]
11. Therapy of congestive heart failure with orally administered taurine.
Azuma J; Hasegawa H; Sawamura A; Awata N; Ogura K; Harada H; Yamamura Y; Kishimoto S
Clin Ther; 1983; 5(4):398-408. PubMed ID: 6871923
[TBL] [Abstract][Full Text] [Related]
12. Chronic cardiotoxicity studies in rabbits with 7-con-O-methylnogarol, a new anthracycline antitumor agent.
McGovren JP; Neil GL; Denlinger RH; Hall TL; Crampton SL; Swenberg JA
Cancer Res; 1979 Dec; 39(12):4849-55. PubMed ID: 498112
[No Abstract] [Full Text] [Related]
13. Similar cardiovascular effects of growth hormone and insulin-like growth factor-I in rats after experimental myocardial infarction.
Tivesten A; Caidahl K; Kujacic V; Sun XY; Hedner T; Bengtsson BA; Isgaard J
Growth Horm IGF Res; 2001 Jun; 11(3):187-95. PubMed ID: 11735233
[TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on beta-adrenoceptor signaling in heart failure produced by myocardial Infarction in rabbits: reversal of altered expression of beta-adrenoceptor kinase and G i alpha.
Makino T; Hattori Y; Matsuda N; Onozuka H; Sakuma I; Kitabatake A
J Pharmacol Exp Ther; 2003 Jan; 304(1):370-9. PubMed ID: 12490614
[TBL] [Abstract][Full Text] [Related]
15. The use of acetyldigoxin in the aged with congestive heart failure.
Aravanis C
Geriatrics; 1969 Sep; 24(9):75-81. PubMed ID: 5811749
[No Abstract] [Full Text] [Related]
16. Alterations of load-induced p38 MAP kinase activation in failing rat hearts.
Yasaka A; Hayashida W
Biochem Biophys Res Commun; 2001 Jul; 285(2):503-7. PubMed ID: 11444871
[TBL] [Abstract][Full Text] [Related]
17. Disparate inotropic and lusitropic responses to pimobendan in conscious dogs with tachycardia-induced heart failure.
Asanoi H; Ishizaka S; Kameyama T; Ishise H; Sasayama S
J Cardiovasc Pharmacol; 1994 Feb; 23(2):268-74. PubMed ID: 7511757
[TBL] [Abstract][Full Text] [Related]
18. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
Rapp JA; Gheorghiade M
Heart Fail Clin; 2005 Apr; 1(1):77-93. PubMed ID: 17386836
[No Abstract] [Full Text] [Related]
19. [The clinical and hemodynamic effects of enalapril and its influence on the peri-infarct area in patients with an acute myocardial infarct].
Dobrotvorskaia TE; Shchukov AA; Gordina OV; Suprun EK; Shardanov NA; Kandoeva MM
Ter Arkh; 1994; 66(8):16-9. PubMed ID: 7985145
[No Abstract] [Full Text] [Related]
20. Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure.
Mehra MR; Lavie CJ; Ventura HO; Milani RV
J Heart Lung Transplant; 2006 Jul; 25(7):834-8. PubMed ID: 16818127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
